Former Cubist, Biogen Execs Head to Editas

Xconomy Boston — 

Cambridge, MA-based Editas Medicine has beefed up its executive ranks as it heads towards an IPO. The company hired former Cubist Pharmaceuticals executive Tim Hunt as its senior vice president of corporate affairs, and named Haiyan Jang, most recently of Biogen, its vice president of preclinical science.